A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy

NCT01732549 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
144
Enrollment
INDUSTRY
Sponsor class

Stopped Development of tasquinimod in prostate cancer discontinued

Conditions

Interventions

Sponsor

Ipsen